Development of the basophil activation test.

• Conditions: anaphylaxis; fast allergic reaction; type 1 allergy; 10001708; 10002426

• Registration Number: NL-OMON32817
• Lead Sponsor: niversitair Medisch Centrum Groningen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 45

Inclusion Criteria

Type 1 allergie for diclofenac, benzophenon-3 or birch pollen.

Exclusion Criteria

Use of immunomodulatory medicine. Current infectious disease or fever.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Reactors to the oral provocation test for diclofenac or to other allergy-tests<br /><br>for subjects allergic to the other allergens are expected to have a greater<br /><br>reaction to the basophil activation test than non-reactors. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>n/a</p><br>